WAVE Life Sciences To Present At The LEERINK Partners 5th Annual Global Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--WAVE Life Sciences Ltd. (NASDAQ: WVE), a genetic medicine company focused on advancing potential best-in-class stereopure nucleic acid therapies, today announced that Paul Bolno, M.D., MBA, President and Chief Executive Officer, will present at the LEERINK Partners 5th Annual Global Healthcare Conference on Thursday, February 11, 2016, at 1:25 p.m. EST at the Waldorf Astoria in New York, NY.